| Bioactivity | NMDAR antagonist 3 (Compound 2) is an antagonist of the NMDA receptor. NMDAR antagonist 3 has a certain but weak inhibitory activity against the NR1A/2B subtype of the NMDA receptor[1]. | ||||||
| CAS | 39512-49-7 | ||||||
| Formula | C11H14ClNO | ||||||
| Molar Mass | 211.69 | ||||||
| Appearance | 固体 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | RT, protect from light
|
||||||
| Reference | [1]. Sui Xiong Cai, et al. Haloperidol analogs and the use thereof. WO1996002250A1. 1996-02-01. |
NMDAR antagonist 3
CAS: 39512-49-7 F: C11H14ClNO W: 211.69
NMDAR antagonist 3 (Compound 2) is an antagonist of the NMDA receptor. NMDAR antagonist 3 has a certain but weak inhibit
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.